View Financial HealthViva Goods 配当と自社株買い配当金 基準チェック /06Viva Goods現在配当金を支払っていません。主要情報0%配当利回り0.1%バイバック利回り総株主利回り0.1%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向0%最近の配当と自社株買いの更新お知らせ • Jun 13Viva Goods Company Limited Approves Dividend for the Year Ended 31 December 2023Viva Goods Company Limited At the AGM held on 11 June 2024 approved the payment of a final dividend of HKD 0.008 per share to the shareholders of the Company and the holders of the outstanding convertible bonds on a converted basis for the year ended 31 December 2023 (the "Final Dividend").お知らせ • Mar 22Viva Goods Company Limited Announces Final Dividend for the Year Ended 31 December 2023, Payable on 22 July 2024Viva Goods Company Limited announced final dividend for the year ended 31 December 2023 of HKD 0.008 per share. The dividend will be payable on 22 July 2024 with Record date of 09 July 2024 and Ex-dividend date of 04 July 2024. Date of shareholders' approval of 11 June 2024.すべての更新を表示Recent updatesお知らせ • May 20Viva Goods Company Limited, Annual General Meeting, Jun 12, 2026Viva Goods Company Limited, Annual General Meeting, Jun 12, 2026, at 14:00 China Standard Time. Location: salon rooms vi-vii, 5/f., harbour grand hong kong, 23 oil street, north point, Hong Kongお知らせ • Mar 11Viva Goods Company Limited to Report Fiscal Year 2025 Results on Mar 24, 2026Viva Goods Company Limited announced that they will report fiscal year 2025 results at 12:30 PM, China Standard Time on Mar 24, 2026お知らせ • Jan 02Viva Goods Company Limited Announces Changes in Committee Compositions, Effect from 1 January 2026Viva Goods Company Limited announced the change in the composition of the nomination committee of the Board (the "Nomination Committee"). Ms. Lyu Hong, a non-executive Director, and Mr. Li Qing, an independent non-executive Director, have been appointed as members of the Nomination Committee with effect from 1 January 2026 (the "NC Appointment"). Following the above changes, the Nomination Committee comprises five members, namely, Mr. Li Ning (chairman), Mr. Pak Wai Keung, Martin, Professor Cui Haitao, Ms. Lyu Hong and Mr. Li Qing.お知らせ • Aug 12Viva Goods Company Limited to Report First Half, 2025 Results on Aug 22, 2025Viva Goods Company Limited announced that they will report first half, 2025 results on Aug 22, 2025お知らせ • Mar 11Viva Goods Company Limited to Report Q4, 2024 Results on Mar 28, 2025Viva Goods Company Limited announced that they will report Q4, 2024 results on Mar 28, 2025お知らせ • Aug 12Viva Goods Company Limited to Report First Half, 2024 Results on Aug 22, 2024Viva Goods Company Limited announced that they will report first half, 2024 results on Aug 22, 2024お知らせ • Jun 13Viva Goods Company Limited Approves Dividend for the Year Ended 31 December 2023Viva Goods Company Limited At the AGM held on 11 June 2024 approved the payment of a final dividend of HKD 0.008 per share to the shareholders of the Company and the holders of the outstanding convertible bonds on a converted basis for the year ended 31 December 2023 (the "Final Dividend").お知らせ • Mar 22Viva Goods Company Limited Announces Final Dividend for the Year Ended 31 December 2023, Payable on 22 July 2024Viva Goods Company Limited announced final dividend for the year ended 31 December 2023 of HKD 0.008 per share. The dividend will be payable on 22 July 2024 with Record date of 09 July 2024 and Ex-dividend date of 04 July 2024. Date of shareholders' approval of 11 June 2024.お知らせ • Mar 02Viva Goods Company Limited to Report Fiscal Year 2023 Results on Mar 20, 2024Viva Goods Company Limited announced that they will report fiscal year 2023 results on Mar 20, 2024お知らせ • Oct 27Viva Goods Company Limited Announces Board and Committee ChangesThe board of directors of Viva Goods Company Limited announced that: Professor Cui Haitao has been appointed as an independent non-executive Director and a member of the nomination committee of the Company with effect from 26 October 2023; and Mr. Wang Yan has resigned as a member of the nomination committee of the Company with effect from 26 October 2023. The biographical details of Professor Cui are as follows: Professor Cui, aged 48, has started his teaching career in tertiary education as Lecturer of Marketing in 2005 at Carlson School of Management in University of Minnesota Twin Cities ("UMN"). He is currently a Deputy Associate Dean for Global DBA Program, Ecolab-Pierson M. Grieve Chair in International Marketing and Professor of Marketing of UMN. He is also an affiliated professor at the Department of Industrial & System Engineering, College of Science & Engineering at UMN. Professor Cui is widely recognized for his contributions in areas of behavioral modeling in marketing, branding, competitive strategies, distribution channels, marketing-operations interfaces, and pricing. He has served as a departmental editor of "OM-Marketing Interface area at Production and Operations Management " and "Customer Experience, Behavior, and Decision-Making area at Service Science " since 2021 and 2019 respectively. He has also served as a guest associate editor for "Management Science " since 2016. He has also been the Vice President of the Behavioral Operations Management and Research Society at Operations Research Society of China since 2015. Professor Cui was also the Vice President of the Production and Operation Management Society College of Behavioral Operations from 2017 to 2019. Professor Cui was selected as the one of the American Marketing Association-Sheth Doctoral Consortium Fellow in 2004, 2017 and 2020 respectively. He received the Meritorious Service Award from 2011 to 2019 by "Management Science " and Distinguished Service Award in 2014 and 2017 and the 3M Non- Tenured Faculty Award from 2007 to 2010. He was nominated to be the MSI Young Scholars in 2011 and the Chang Jiang Scholars by Ministry of Education of China in 2016. Professor Cui obtained his Bachelor's Degree in Industrial Engineering and Degree in Fluid Machinery and Fluid Engineering and International Master of Business Administration from Tsinghua University in 1998 and 2000. He received his Master of Business Administration in Operations and Information Management and Doctor of Philosophy in Managerial Science & Applied Economics from Wharton School of University of Pennsylvania in 2002 and 2005 respectively.お知らせ • Aug 05Viva Goods Company Limited to Report First Half, 2023 Results on Aug 18, 2023Viva Goods Company Limited announced that they will report first half, 2023 results on Aug 18, 2023お知らせ • Nov 25Viva China Holdings Limited Announces Change of Members of the Remuneration CommitteeThe board of directors of Viva China Holdings Limited announced that due to adjustment of work arrangement, Ms. Lyu Hong, a non-executive Director of the Company, has been appointedas a member of the remuneration committee (the "Remuneration Committee") of the Company, and Mr. Li Ning, an executive Director and the chairman of the Board and Mr. Pak Wai Keung, Martin, an independent non-executive Director, have ceased to serve as a member of the Remuneration Committee, both with effect from 24 November 2022. The Remuneration Committee after such change comprises two independent non-executive Directors, namely Mr. Wang Yan and Mr. Li Qing, and one non-executive Director, namely Ms. Lyu Hong, with Mr. Wang Yan as the chairman of the Remuneration Committee.お知らせ • Nov 19Viva China Holdings Limited Appoints Lyu Hong as Non-Executive DirectorThe board of directors of Viva China Holdings Limited announced that Ms. Lyu Hong (Ms. Lyu) has been appointed as a non-executive Director with effect from 18 November 2022 (the Appointment). Ms. Lyu Hong (also known as Lu Hong), aged 51, has over 20 years of experience in global human resources management. She joined Pfizer Pharmaceuticals Limited a group, member of Pfizer Inc.in September 1993 and started her career in the industry as a human resources learning and development manager in the PRC in August 1997. Since then, she progressed through increasingly senior human resources leadership positions within Pfizer Group. From June 2011 to August 2016, she was employed by Pfizer Business Service (Dalian) Co. Ltd. served as the vice president and of human resources for the Asia Pacific region, leading a human resources team consisting of 260 team members which provided human resources and strategic management services to all business units, senior management and more than 30,000 employees across 15 Asia Pacific countries or regions. In 2016, Ms. Lyu was appointed as the vice president of the global human resources operations based in the New York headquarters of Pfizer Group and was subsequently redesignated as a senior vice president of human resources and relocated to Shanghai after the establishment of Pfizer's Upjohn division in December 2018. Upon the merger of Pfizer 's Upjohn business (its primarily off-patent branded and generic established medicines business) with Mylan N.V. (a global pharmaceutical company) forming Viatris Inc. in November 2020, Ms. Lyu has been redesigned to be employed by Upjohn US Employment Inc. (a group member of Viatris Inc.) and currently as the head of human resources for Greater China region and Japan, Australia and New Zealand region. Ms. Lyu had been a director of C&J Clark (No 1) Limited (Clark) from February 2021 to December 2021 before Clark became a subsidiary of the Group. Ms. Lyu also previously acted as a non-executive director of Pfizer Limited from December 2015 to November 2016. Ms. Lyu obtained an executive master of business administration degree from Peking University in July 2006, and also obtained a bachelor degree in economy, major in international economy and trade, (through long distance online) from Dongbei University of Finance and Economics in January 2007.お知らせ • Nov 02Viva China Holdings Limited to Report Q3, 2022 Results on Nov 11, 2022Viva China Holdings Limited announced that they will report Q3, 2022 results at 4:00 PM, China Standard Time on Nov 11, 2022お知らせ • Jul 30Viva China Holdings Limited to Report First Half, 2022 Results on Aug 12, 2022Viva China Holdings Limited announced that they will report first half, 2022 results on Aug 12, 2022決済の安定と成長配当データの取得安定した配当: VVCH.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: VVCH.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Viva Goods 配当利回り対市場VVCH.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (VVCH.F)0%市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Luxury)2.4%アナリスト予想 (VVCH.F) (最長3年)n/a注目すべき配当: VVCH.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: VVCH.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: VVCH.F US市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: VVCH.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/23 06:49終値2026/06/15 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Viva Goods Company Limited 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Chongguang FengCitic Securities Co., Ltd.
お知らせ • Jun 13Viva Goods Company Limited Approves Dividend for the Year Ended 31 December 2023Viva Goods Company Limited At the AGM held on 11 June 2024 approved the payment of a final dividend of HKD 0.008 per share to the shareholders of the Company and the holders of the outstanding convertible bonds on a converted basis for the year ended 31 December 2023 (the "Final Dividend").
お知らせ • Mar 22Viva Goods Company Limited Announces Final Dividend for the Year Ended 31 December 2023, Payable on 22 July 2024Viva Goods Company Limited announced final dividend for the year ended 31 December 2023 of HKD 0.008 per share. The dividend will be payable on 22 July 2024 with Record date of 09 July 2024 and Ex-dividend date of 04 July 2024. Date of shareholders' approval of 11 June 2024.
お知らせ • May 20Viva Goods Company Limited, Annual General Meeting, Jun 12, 2026Viva Goods Company Limited, Annual General Meeting, Jun 12, 2026, at 14:00 China Standard Time. Location: salon rooms vi-vii, 5/f., harbour grand hong kong, 23 oil street, north point, Hong Kong
お知らせ • Mar 11Viva Goods Company Limited to Report Fiscal Year 2025 Results on Mar 24, 2026Viva Goods Company Limited announced that they will report fiscal year 2025 results at 12:30 PM, China Standard Time on Mar 24, 2026
お知らせ • Jan 02Viva Goods Company Limited Announces Changes in Committee Compositions, Effect from 1 January 2026Viva Goods Company Limited announced the change in the composition of the nomination committee of the Board (the "Nomination Committee"). Ms. Lyu Hong, a non-executive Director, and Mr. Li Qing, an independent non-executive Director, have been appointed as members of the Nomination Committee with effect from 1 January 2026 (the "NC Appointment"). Following the above changes, the Nomination Committee comprises five members, namely, Mr. Li Ning (chairman), Mr. Pak Wai Keung, Martin, Professor Cui Haitao, Ms. Lyu Hong and Mr. Li Qing.
お知らせ • Aug 12Viva Goods Company Limited to Report First Half, 2025 Results on Aug 22, 2025Viva Goods Company Limited announced that they will report first half, 2025 results on Aug 22, 2025
お知らせ • Mar 11Viva Goods Company Limited to Report Q4, 2024 Results on Mar 28, 2025Viva Goods Company Limited announced that they will report Q4, 2024 results on Mar 28, 2025
お知らせ • Aug 12Viva Goods Company Limited to Report First Half, 2024 Results on Aug 22, 2024Viva Goods Company Limited announced that they will report first half, 2024 results on Aug 22, 2024
お知らせ • Jun 13Viva Goods Company Limited Approves Dividend for the Year Ended 31 December 2023Viva Goods Company Limited At the AGM held on 11 June 2024 approved the payment of a final dividend of HKD 0.008 per share to the shareholders of the Company and the holders of the outstanding convertible bonds on a converted basis for the year ended 31 December 2023 (the "Final Dividend").
お知らせ • Mar 22Viva Goods Company Limited Announces Final Dividend for the Year Ended 31 December 2023, Payable on 22 July 2024Viva Goods Company Limited announced final dividend for the year ended 31 December 2023 of HKD 0.008 per share. The dividend will be payable on 22 July 2024 with Record date of 09 July 2024 and Ex-dividend date of 04 July 2024. Date of shareholders' approval of 11 June 2024.
お知らせ • Mar 02Viva Goods Company Limited to Report Fiscal Year 2023 Results on Mar 20, 2024Viva Goods Company Limited announced that they will report fiscal year 2023 results on Mar 20, 2024
お知らせ • Oct 27Viva Goods Company Limited Announces Board and Committee ChangesThe board of directors of Viva Goods Company Limited announced that: Professor Cui Haitao has been appointed as an independent non-executive Director and a member of the nomination committee of the Company with effect from 26 October 2023; and Mr. Wang Yan has resigned as a member of the nomination committee of the Company with effect from 26 October 2023. The biographical details of Professor Cui are as follows: Professor Cui, aged 48, has started his teaching career in tertiary education as Lecturer of Marketing in 2005 at Carlson School of Management in University of Minnesota Twin Cities ("UMN"). He is currently a Deputy Associate Dean for Global DBA Program, Ecolab-Pierson M. Grieve Chair in International Marketing and Professor of Marketing of UMN. He is also an affiliated professor at the Department of Industrial & System Engineering, College of Science & Engineering at UMN. Professor Cui is widely recognized for his contributions in areas of behavioral modeling in marketing, branding, competitive strategies, distribution channels, marketing-operations interfaces, and pricing. He has served as a departmental editor of "OM-Marketing Interface area at Production and Operations Management " and "Customer Experience, Behavior, and Decision-Making area at Service Science " since 2021 and 2019 respectively. He has also served as a guest associate editor for "Management Science " since 2016. He has also been the Vice President of the Behavioral Operations Management and Research Society at Operations Research Society of China since 2015. Professor Cui was also the Vice President of the Production and Operation Management Society College of Behavioral Operations from 2017 to 2019. Professor Cui was selected as the one of the American Marketing Association-Sheth Doctoral Consortium Fellow in 2004, 2017 and 2020 respectively. He received the Meritorious Service Award from 2011 to 2019 by "Management Science " and Distinguished Service Award in 2014 and 2017 and the 3M Non- Tenured Faculty Award from 2007 to 2010. He was nominated to be the MSI Young Scholars in 2011 and the Chang Jiang Scholars by Ministry of Education of China in 2016. Professor Cui obtained his Bachelor's Degree in Industrial Engineering and Degree in Fluid Machinery and Fluid Engineering and International Master of Business Administration from Tsinghua University in 1998 and 2000. He received his Master of Business Administration in Operations and Information Management and Doctor of Philosophy in Managerial Science & Applied Economics from Wharton School of University of Pennsylvania in 2002 and 2005 respectively.
お知らせ • Aug 05Viva Goods Company Limited to Report First Half, 2023 Results on Aug 18, 2023Viva Goods Company Limited announced that they will report first half, 2023 results on Aug 18, 2023
お知らせ • Nov 25Viva China Holdings Limited Announces Change of Members of the Remuneration CommitteeThe board of directors of Viva China Holdings Limited announced that due to adjustment of work arrangement, Ms. Lyu Hong, a non-executive Director of the Company, has been appointedas a member of the remuneration committee (the "Remuneration Committee") of the Company, and Mr. Li Ning, an executive Director and the chairman of the Board and Mr. Pak Wai Keung, Martin, an independent non-executive Director, have ceased to serve as a member of the Remuneration Committee, both with effect from 24 November 2022. The Remuneration Committee after such change comprises two independent non-executive Directors, namely Mr. Wang Yan and Mr. Li Qing, and one non-executive Director, namely Ms. Lyu Hong, with Mr. Wang Yan as the chairman of the Remuneration Committee.
お知らせ • Nov 19Viva China Holdings Limited Appoints Lyu Hong as Non-Executive DirectorThe board of directors of Viva China Holdings Limited announced that Ms. Lyu Hong (Ms. Lyu) has been appointed as a non-executive Director with effect from 18 November 2022 (the Appointment). Ms. Lyu Hong (also known as Lu Hong), aged 51, has over 20 years of experience in global human resources management. She joined Pfizer Pharmaceuticals Limited a group, member of Pfizer Inc.in September 1993 and started her career in the industry as a human resources learning and development manager in the PRC in August 1997. Since then, she progressed through increasingly senior human resources leadership positions within Pfizer Group. From June 2011 to August 2016, she was employed by Pfizer Business Service (Dalian) Co. Ltd. served as the vice president and of human resources for the Asia Pacific region, leading a human resources team consisting of 260 team members which provided human resources and strategic management services to all business units, senior management and more than 30,000 employees across 15 Asia Pacific countries or regions. In 2016, Ms. Lyu was appointed as the vice president of the global human resources operations based in the New York headquarters of Pfizer Group and was subsequently redesignated as a senior vice president of human resources and relocated to Shanghai after the establishment of Pfizer's Upjohn division in December 2018. Upon the merger of Pfizer 's Upjohn business (its primarily off-patent branded and generic established medicines business) with Mylan N.V. (a global pharmaceutical company) forming Viatris Inc. in November 2020, Ms. Lyu has been redesigned to be employed by Upjohn US Employment Inc. (a group member of Viatris Inc.) and currently as the head of human resources for Greater China region and Japan, Australia and New Zealand region. Ms. Lyu had been a director of C&J Clark (No 1) Limited (Clark) from February 2021 to December 2021 before Clark became a subsidiary of the Group. Ms. Lyu also previously acted as a non-executive director of Pfizer Limited from December 2015 to November 2016. Ms. Lyu obtained an executive master of business administration degree from Peking University in July 2006, and also obtained a bachelor degree in economy, major in international economy and trade, (through long distance online) from Dongbei University of Finance and Economics in January 2007.
お知らせ • Nov 02Viva China Holdings Limited to Report Q3, 2022 Results on Nov 11, 2022Viva China Holdings Limited announced that they will report Q3, 2022 results at 4:00 PM, China Standard Time on Nov 11, 2022
お知らせ • Jul 30Viva China Holdings Limited to Report First Half, 2022 Results on Aug 12, 2022Viva China Holdings Limited announced that they will report first half, 2022 results on Aug 12, 2022